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Background  and  purpose      Previous  studies  on  shoulder 
arthroplasty  have  usually  described  small  patient  populations, 
and few articles have addressed the survival of shoulder implants. 
We describe the results of shoulder replacement in the Norwegian 
population (of 4.7 million) during a 12-year period. Trends in the 
use of shoulder arthroplasty during the study period were also 
investigated. 
Patients and methods   1,531 hemiprostheses (HPs), 69 total 
shoulder replacements (Neer type TSR), and 225 reversed total 
shoulder replacement (reversed TSR) operations were reported 
to the Norwegian Arthroplasty Register between 1994 and 2005. 
Kaplan-Meier failure curves were drawn up for particular sub-
groups of patients, and revision rates were calculated using Cox 
regression analysis.
Results   The 5- and 10-year failure rates of hemiprostheses 
were 6% (95% CI: 5–7) and 8% (95% CI: 6–10), and for reversed 
total shoulder replacements they were 10% (95% CI: 5–15) and 
22% (95% CI: 10–33), respectively. For hemiprostheses, the risk 
of revision for patients who were 70 years or older was half that of 
those who were younger (RR = 0.47, CI: 0.28–0.77), while the risk 
of revision was highest for patients with sequelae after fracture 
compared to those with acute fractures (RR = 3.3, CI: 1.5–7.2). 
No differences in prosthesis survival were found between the dif-
ferent hemiprosthesis brands. The main reasons for revision of 
hemiprostheses were pain and luxation. For reversed total pros-
theses, the risk of revision was less for women than for men (RR = 
0.26, CI: 0.11–0.63), and the main cause of revision was aseptic 
loosening of the glenoid component. During the study period, the 
incidence  of  shoulder  arthroplasty  increased  for  all  diagnostic 
groups except inflammatory arthritis, for which a decrease was 
seen. 
Interpretation   We found good results in terms of 5-year pros-
thesis failure rate, with the use of hemiarthroplasty for patients 
with inflammatory arthritis, osteoarthritis, and acute fractures. 
Reversed total shoulder replacement was associated with a rather 
poor prognosis.      
Shoulder replacement surgery was introduced as a treatment 
method for 3- or 4-part proximal humerus fractures by Neer 
in the 1950s (Neer et al. 1953). During the 1970s, the use of 
shoulder arthroplasty was extended to include patients with 
osteoarthritis  (Neer  1974),  and  this  treatment  method  was 
eventually used with success in other diagnostic groups such 
as inflammatory arthritis. 
Loosening of the glenoid component has been shown to be a 
major problem in total shoulder arthroplasty (Cofield and Edg-
erton 1990, Torchia et al. 1997, Bohsali et al. 2006). However, 
pain due to glenoid arthritis has been described after hemiar-
throplasty (Parsons et al. 2004, Haines et al. 2006). Previous 
studies on revision after shoulder arthroplasty have usually 
included small samples, and they have rarely compared sur-
vival between groups. In a study of total shoulder arthroplasty, 
the survival rates were 95% at 5 years and 85% at 10 years 
(Martin et al. 2005). Haines et al. (2006) found different sur-
vival rates according to the primary diagnosis, the 10-year 
survival being 86% for patients with osteoarthritis and 33% 
for posttraumatic arthritis. In proximal humerus fractures, sur-
vival of the prosthesis has been reported to be 83–94% at 10 
years (Robinson et al. 2003, Kwon and Zuckerman 2005), and 
a study of patients with rheumatoid arthritis reported prosthe-
sis survival at 8 years to be 92% (Trail and Nuttall 2002).
We evaluated prosthesis failure after shoulder replacement 
in a large national series of patients, and we investigated the   
effect  of  prosthesis  type  and  shoulder  disease  on  the  out-
come. Furthermore, we assessed trends in the use of shoulder 
arthroplasty over a 12-year period.
Patients and methods
The Norwegian Arthroplasty Register (NAR) was established 
in 1987, initially as a hip prosthesis register. In January 1994, 
it was extended to include all artificial joints (Havelin 1999). 84  Acta Orthopaedica 2009; 80 (1): 83–91
Individual reports of joint replacements were received from all 
the hospitals in Norway that were performing arthroplasty sur-
gery. Data concerning identity of the patient, diagnosis, date of 
surgery, type of prosthesis, whether cement was used, whether 
the operation was primary or a revision, cause of revision, and 
procedure at revision were taken from the form filled in by 
the operating surgeon (Furnes et al. 2002). The completeness 
of registration was evaluated in a recent study and 89% of all 
primary shoulder arthroplasty operations were reported to the 
NAR (Espehaug et al. 2006). In the present study involving 
1,825 shoulder arthroplasties, the main outcome variable was 
whether or not a revision was performed after primary sur-
gery. No information on function or patient satisfaction was 
registered. 
From 1994 through 2005, 1,531 hemiprosthesis procedures 
and 294 total shoulder replacement procedures were reported 
to the NAR. A reversed total prosthesis was used in 225 cases 
and a Neer-type total prosthesis was used in 69 cases. Mean 
age of the patients operated with a reversed prosthesis was 69 
years, which was practically the same as in the total material 
(Table 1). There were 1,428 women and 397 men, and the mean 
age at surgery was significantly higher in women (70 years for 
women as opposed to 64 years for men) (p <   0.001). 
During the study period, 13 different brands of shoulder 
prostheses were used (Table 2). The most commonly used 
type, the “Neer-type”, consisted of a stem and a caput and, for 
total shoulder replacements, a glenoid component. They were 
inserted with or without cement. The Delta I prosthesis differs 
from the others in having a hydroxyapatite-coated surface. 
The Delta III total shoulder replacement (DePuy Interna-
tional Ltd. Leeds, England) represents a separate entity using 
the reversed design with a glenoid head and humeral cup. The 
Copeland prostheses (Biomet Merck Limited, South Wales, 
UK) as well as 42 of the Scan prostheses were resurfacing 
prostheses. 
132 patients were given shoulder replacements bilaterally 
during the study period. In these patients, each replacement 
procedure was considered a separate case. A revision (or fail-
ure) was defined as the removal or exchange of part of or the 
whole implant. The follow-up time was the time from primary 
shoulder replacement until revision, or until the end of the study 
or death. The date of death for the patients was obtained from 
Statistics Norway (www.ssb.no/english/). Median follow-up 
time was 4.0 years (range: 2 days to 12 years). 
Table 1. General characteristics and diseases leading to shoulder 
replacement
Diagnosis a   Total no.    Hemi-    Reversed  Neer-type 
  of patients  prosthesis   TSR   TSR
Total   1,820   1,526  225   69
Age (mean, SD)   69 (12)   69 (13)   69 (11)   68 (11)
Sex (% women)   78%   78%   83%   69%
Diagnosis    
  Osteoarthritis   427    338      50   39
   Rheumatoid 
      arthritis   569    439    118   12
 Acute fracture   426    422        4    –
 Fracture sequelae   350    303      34   13
   Ankylosing
      spondylitis     16      14        1     1
  Psoriatic arthritis     18      15        3    –
   Rotator cuff / 
      ligament damage    23      10      13   –
   Other b     64      48      11     5
a More than one diagnosis was allowed.
b Avascular necrosis, sequelae after infection, hemophilia, cancer, 
sequelae after luxation, SLE, chondrocalcinosis, sequelae after 
frozen shoulder, synovial chondromatosis, and unknown.
Table 2. Prosthesis brands
Prosthesis brand   HP   Neer-    Reversed   Hospitals     Hospitals     Hospitals     Hospitals  
    type  TSR   using the  with > 10  using the  with > 10
    TSR    HP  HPs a  TSR  TSRs a
Bio-Modular (Biomet )   604   48      26   14 (7)   9   2
Global (DePuy)   261     1      21     8 (3)   1  0
Delta III (DePuy)         225         17   6 (3)
Copeland (Biomet)   121    4      15     3 (2)   3   0
Nottingham (Biomet)   109   13      4     2 (2)   1   1
Global Advantage (DePuy)   105     1      15     1 (1)   1   0
Global Fx(DePuy)   119         17     0  
Delta I (Medinov)     58         7     2 (1)  
Scan Shoulder (Mitab)     56         7    2  
Neer II (3M Healthcare)     40         6     1  
Modular (3M Healthcare)     33         1     1 (1)  
Monospherical (Howmedica)    13     1      3     0   1   0
Bigliani Flatow (Zimmer)      6         2     0  
   1,525 b   68 b   225  
  
HP: hemiprosthesis; TSR: total shoulder replacement.
a Number in parentheses: hospitals with > 30 procedures
b For one TSR and one HP, the brand of prosthesis was not given. Acta Orthopaedica 2009; 80 (1): 83–91  85
Major causes of surgery were rheumatoid arthritis (RA), 
osteoarthritis  (OA),  acute  fracture,  and  fracture  sequelae 
(Table 1). Only 4 patients with acute fractures had a TSR, 
while TSR was used more commonly for the other major diag-
nostic groups.
In some analyses (Table 4, Figures 1 and 3), rheumatoid 
arthritis, psoriatic arthritis, and ankylosing spondylitis were 
grouped together and called inflammatory arthritis (IA). Sev-
eral causes of revision could be given for the same patient 
(Table 5). For the purpose of this study, however, pain was 
only registered as the cause of revision in cases where this was 
the only recorded cause.
Statistics
The Student t-test was used to compare continuous variables. 
The significance level was set at 5% and all p-values were 
two-tailed. Median follow-up (observation) time was calcu-
lated using the reverse Kaplan-Meier method. Kaplan-Meier 
survival tables were used to find 5- and 10-year failure rates, 
calculated as 1 minus the survival rate. Failure curves based 
on the Kaplan-Meier method with revision for any reason as 
endpoint were given for several subgroups of patients. The 
failure curves were discontinued when the number of patients 
at risk was less than 20. In failure curves for different brands 
of hemiprosthesis, only brands that had been used in at least 
30 shoulders were included in the analyses (Figure 3a). The 
curve for Global Fx was not shown because the follow-up time 
was short (median 1.3 years). 
Cox multiple regression analysis was used to calculate rela-
tive risk (RR) of revision according to shoulder disease, age, 
sex, and year of primary operation. Separate analyses were 
done for hemiprostheses and reversed total shoulder replace-
ments (Table 5). All relative risks were adjusted for the other 
variables  in  the  analysis.  A  Cox  regression  analysis  was 
also  done  to  compare  resurfacing  hemiprostheses  to  other 
hemiprostheses. The analysis is not shown, but the p-value 
given in the text was obtained from this analysis.
For revision due to specific causes (such as aseptic loosening 
or infection), the number of events was small with occasional 
zeros (Table 6), which is why models for exact Cox regres-
sion were set up. The statistical program LogXact (Cytel Inc., 
Cambridge, MA) was used according to Samuelsen (2003). 
The models were adjusted for shoulder disease, cement, sex, 
and age. 
Poisson  regression  analysis  was  used  to  analyze  trends 
in the incidence of shoulder arthroplasties for all shoulder 
arthroplasties and for HP and TSR separately (Table 3), and 
for the 4 major diagnostic groups (Figure 1). These analyses 
were performed based on annual population rates for the Nor-
wegian population obtained from Statistics Norway. The p-
values given in Table 3 and in the legend to Figure 1 were 
derived  from  these  Poisson  analyses. All  analyses,  except 
for the exact regression analyses (LogXact), were performed 
using SPSS software version 13.0.
Results
Time trends 
An increase in the overall incidence of shoulder arthroplasties 
took place during the 12-year study period, and this trend was 
seen for HP but not for TSR (p < 0.001 and p = 0.3) (Table 
3). The increasing trend was seen in all the major diagnostic 
groups except inflammatory arthritis, for which the trend was 
opposite (p < 0.001) (Figure 1).
Table 3. Primary shoulder arthroplasties per annum. Overall inci-
dence (per 100,000 inhabitants), total annual number, and annual 
number according to prosthesis type 
Year  Overall  All primary  Hemi-  Total 
  incidence  operations  prostheses  prostheses
1994   2,80   121   93   28
1995   2,67   116   87   29
1996   2,77   121   94   27
1997   3,37   148   133   15
1998   2,90   128   118   10
1999   3,55   158   135   23
2000   3,13   140   114   26
2001   3,24   146   130   16
2002   3,34   151   122   29
2003   3,98   181   153   28
2004   4,33   198   168   30
2005   4,71   217   184   33
Total      1820   1526   294
p-value a   < 0.001   < 0.001   < 0.00  0.31
a p-value calculated using Poisson regression analysis based on 
annual population rates for the Norwegian population. Figure 1. Shoulder arthroplasties in 4 major diagnostic groups from 
1994 through 2005. IA: inflammatory arthritis; OA: osteoarthritis.
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Operation volume
The shoulder replacements were performed at 54 hospitals. 
On average, 4 procedures were done per hospital per year, 
and only 2 hospitals had 10 or more procedures annually. The 
mean number of HP operations performed per hospital during 
the study period was 28 (1–176) while for reversed TSR the 
mean was 13 (1–74) procedures per hospital that performed 
TSR (p = 0.01). 7 HP brands and 1 TSR brand had a relatively 
high volume in at least one hospital (> 30 cases during the 
study period) (Table 1). 
Revision procedures 
The procedures performed at revision after TSR were exchange 
of parts of or the whole prosthesis in 22 patients, and removal 
of prosthetic parts without replacement in 14 cases. In 2 cases, 
the procedure performed during revision was not reported. In 
patients with HP, removal of prosthesis or prosthesis com-
ponents was performed in 11 cases, while in 61 patients the 
whole prosthesis or parts were exchanged. The procedure was 
not reported in 3 cases with HP. 
Revision after hemiarthroplasty
The cumulative 5- and 10-year failure rates for HP were 6% 
and 8% (Figure 2). When analyzing resurfacing hemiprosthe-
ses separately, there was no statistically significant difference 
between these prostheses and other HPs (p = 0.9) (Figure 2). 
No statistically significant difference in failure rate was found 
between the different brands of hemiprosthesis (Figure 3a). 
Shoulder disease did, however, influence the failure rate, and 
for  hemiprostheses  the  failure  rate  was  lowest  for  patients 
with an acute fracture and highest after fracture sequelae (p = 
0.01) (Figure 3b). Cox regression analysis showed that the 
relative risk of revision was 3.3 (CI: 1.5–7.2) for patients with 
sequelae after fractures compared to those with acute fractures 
(Table 4a).
The median follow-up time was longer for patients with 
IA  (6.1  years)  than  for  those  with  OA  (2.9  years),  acute 
fracture (3.3 years), and sequelae after fracture (3.5 years) 
(p < 0.001). 
Furthermore, patients who were 70 years old or more had 
half the risk of revision compared to those who were younger 
Figure 2.. Kaplan-Meier failure curve (with 95% CI shown in color) for all hemiprostheses, resurfacing hemiprostheses, reversed total shoulder 
replacement, and Neer-type total shoulder replacement.
All hemiprostheses
Reversed total prostheses Neer total prostheses
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(RR = 0.47, CI: 0.28–0.77) (Table 4a), while the risk of revi-
sion was independent of gender and year of operation. Cemen-
tation of the humeral component had no influence on revision 
rate (RR = 1.1, CI = 0.67–1.8) (not presented in the table). 
Revision after total shoulder arthroplasty
The 5- and 10-year failure rates for the reversed TSR were 
10% and 22% (Figure 2). The failure curve for Neer-type TSR 
shows 5- and 10-year revision rates of 20% and 27% (Figure 
2). The Cox regression analysis did not reveal any difference 
in revision rates between the 3 major diagnostic groups for 
reversed TSR (Table 4b). Women had a lower risk of revision 
than men (RR = 0.26, CI: 0.11–0.63) (Table 4b). 
Causes of revision
The main cause of revision after TSR was aseptic loosening 
of the glenoid component (Table 5). For hemiprostheses, the 
major cause of revision was pain, seen in 15 of 439 cases with 
RA but in none of the 422 cases with acute fractures. Alto-
gether, this was given as the only cause of revision in 32 cases. 
Other major causes of revision are listed in Table 5. 
For hemiprostheses, revision due to pain was less frequent 
in patients with acute fractures (RR = 0.12, p = 0.02) and in 
patients > 70 years of age (RR = 0.25, p = 0.005) (Table 6a). 
In HP patients with sequelae after fractures, revision due to 
instability and luxation was more common (RR = 11, p = 0.04 
and RR = 8.8, p = 0.04, respectively) (Table 6a). 
Figure 3. A. Kaplan-Meier failure curves for different hemiprosthesis brands. Groups with less than 20 patients were excluded. B. Kaplan-Meier 
failure curves according to shoulder disease. 
p = 0.18 p = 0.01

































Table 4a. Cox regression analysis for revision after hemiarthroplasty, according to potential explanatory factors. 5- and 
10-year failure rates estimated using the Kaplan-Meier method
  No.   No. of    F5 (%)   95% CI   F10 (%)   95% CI   RR   95% CI   p-value
    revisions
All   1,470 a   74    6   5–7   8   6–10  
Age
  0–69 years    664  49    9  7–12  12  9–15  1
  ≥ 70 years    806   25    4  3–5  4  3–5  0.47  0.28–0.77  0.003     
Sex
  Men    312  14    6  3–10  8  4–12  1
  Women  1158  60    6  5–8  8  6–10  1.5  0.82–2.7  0.2       
Year of surgery                    1.0   0.92–1.1   1
Diagnosis 
  Acute fracture    422    9    1  0–2  3  1–4   1
  IA b    440  28    6  3–8  9  6–12  1.8  0.80–3.9  0.1
  OA b     311  14    6  3–9  9  4–14  2.2  0.95–5.1  0.07
  Fracture   
    sequelae    297  23   10  6–14  10  6–14  3.3   1.5–7.2  0.002
   
a 61 ca ses were not included due to missing values or due to the fact that the patient had a shoulder disease other than 
the 4 included in this analysis.
b OA: osteoarthritis; IA: inflammatory arthritis including RA, psoriatic arthritis, and ankylosing spondylitis.
F5 and F10: unadjusted Kaplan-Meier 5-year and 10-year failure rates.
RR: relative risk of revision derived from the Cox model.88  Acta Orthopaedica 2009; 80 (1): 83–91
For reversed TSR, women had a smaller risk of revision due 
to deep infections than men (RR = 0.006, p = 0.01) (Table 
6b). Except for this, no statistically significant differences 
in revision due to the causes given in Table 6, were found 
between patients with different shoulder diseases and fixation 
methods. 
Discussion
Our patient series is among the largest in studies on hemipros-
theses of the shoulder. The major finding was that the survival 
after insertion of a hemiprosthesis was satisfactory, with 6% 
and 8% revision within 5 and 10 years, respectively. For the 
reversed TSR, however, the results were more disappointing 
with more than 20% revision at 10 years. 
The age and sex distribution was similar to that in some other 
large series (Jain et al. 2004, Sharma and Dreghorn 2006). In 
our study, there were 84% hemiprostheses, which is similar 
to the findings from the Scottish and Swedish registries (88% 
and 87%, respectively) (Rahme et al. 2001, Sharma and Dreg-
horn 2006). Ravenscroft and Calvert (2004) reported twice as 
many HPs as TSRs in the UK, but there were more TSRs in a 
large American study (Jain et al. 2004). 
Time trends
There was an increase in the overall incidence of shoulder 
arthroplasty during the 12-year period. A similar trend was 
recently described in a review by Bohsali et al. (2006). In the 
Norwegian population, the increased incidence only applied 
to hemiprostheses while no significant change in the incidence 
of total shoulder replacement (TSR) was detected. Jain et al., 
investigating time trends for TSR in the United States, found a 
minor increase in the use of TSR during the period 1990–2000 
(Jain et al. 2006). 
We found an increase in the use of shoulder replacement 
for patients with osteoarthritis, fracture sequelae, and acute 
fractures, but the opposite trend was seen for patients with 
IA. This corresponds well with the trend in the US population 
reported by Jain et al. (2006), showing an increase in the use 
of TSR due to osteoarthritis and a minor decline for rheuma-
toid arthritis. The findings correspond well with the general 
trend towards reduced need for surgical procedures in patients 
with rheumatic diseases (Fevang et al. 2007). 
Table 4b. Cox regression survival analysis for revision after reversed TSR, according to potential explanatory 
factors. 5- and 10-year failure rates estimated using the Kaplan-Meier method
  No.   No. of    F5 (%)   95% CI   F10 (%)   95% CI   RR   95% CI   p-value
    revisions
All    201 a   22   10   85–95   22   67–90   
Age
  0–69 years    93  13  11    4–18  26  11–41  1
  ≥ 70 years   108  9  8    3–14   12    3–20   0.82  0.32–2.12   0.7
Sex
  Men    32  9  30  11–50  51  23–80  1 
  Women   169  13  7    2–11  15    4–26  0.26  0.11–0.63  0.003  
Year of surgery                   1.09   0.93–1.3   0.3
Diagnosis 
  IA b  120  14  9    3–14  20    8–32  1
  OA b     47  6  14    1–28  36    0–73  1.49  0.52–4.3  0.5
  Fracture    
    sequelae    34   2  10    0–23  10    0–23  0.64   0.14–2.9   0.6  
a 24 cases were not included due to missing values or due to the fact that the patient had a shoulder disease other 
than the 3 included in this analysis.
b OA: osteoarthritis; IA: inflammatory arthritis including RA, psoriatic arthritis, and ankylosing spondylitis.
F5 and F10: unadjusted Kaplan-Meier 5-year and 10-year failure rates.
RR: relative risk of revision derived from the Cox model.
Table 5. Causes of revision, according to type of prosthesis
Cause a   All  Hemiprosthesis  TSR reversed
    (n = 1,820)   (n = 1,526)  (n = 225) 
Aseptic loosening of 
   glenoid component    17   –   13
   humeral component    11   6   5
Luxation   21   11   4
Instability   9   6   2
Deep infection   11   5   5
Fracture   3   2   1
Pain   34   32   2
Failure of function   3   3   –
Other b   26   20   4
a More than one cause may have been given, but pain was included 
only when it was given as the sole cause of revision.
b Including incorrect axis, broken prosthesis component, component 
too small or too large, subluxation, and other not specified.Acta Orthopaedica 2009; 80 (1): 83–91  89
Operation volume
In a recent study of knee replacements, the revision rate was 
found to be lower at hospitals having a high volume of opera-
tions (Furnes et al. 2007). Jain et al. (2004) found better out-
come  in  terms  of  in-hospital  mortality  and  complications, 
length of stay, and disposition of patients on discharge, after 
shoulder arthroplasty performed in high-volume hospitals. In 
our study, none of the hospitals had a high volume of shoul-
der surgery, and the procedures at the “high-volume hospitals” 
may have been performed by several different surgeons. Still, 
the average number of procedures was lower for the reversed 
TSRs and this may have contributed to the inferior results. 
Revision after hemiarthroplasty
The overall 5-year failure rate for hemiprostheses (6%) in our 
study is acceptable; it is similar to the 4% overall 5-year fail-
ure rate for knee prostheses (Havelin et al. 2000) and 4% for 
hip prostheses (in patients with osteoarthritis) (Furnes et al. 
2001). However, the threshold for revising a hip prosthesis 
may be different from that for shoulder prostheses. We have 
Table 6a. Risk of revision due to specific causes, for hemiprostheses (HPs), according to shoulder disease and fixation. The results were 
obtained using an exact regression model 
  Aseptic loosening   Pain d   Deep infection   Instability   Luxation of prosthesis
  n a   RR b   p  n a  RR b   p  n a  RR b  p   n a   RR b  p   n a    RR b  p
    (95% CI)        (95% CI)      (95% CI)      (95% CI)      (95% CI)  
Shoulder disease  
  IA c (439)  4  1    15  1  1  1      0  1    0  1
  OA c (311)  2  1.1  1.0  5  1.0  1.0   2  2.5  0.87  1  4.2    0.38  2   2.8   0.4
      (0.09–9.0)      (0.28–3.1)      (0.12–156)      (0.11–∞)      (0.22–∞)
  Sequelae of  1  0.53   0.99  8  1.5  0.52  1  1.4  1.0  3   11.4   0.04   5   8.8    0.04
  fracture (296)    (0.01–5.7)      (0.53–3.8)      (0.02–119)      (1.1–∞)      (1.1–∞)
  Acute fracture   0  0.28  0.27  0   0.12  0.02  0   1.1    1.0   1  1.8    0.72  2   1.7   0.7
  (421)    (0.0–2.5)      (0.0–0.80)      (0.0–41)      (0.05–∞)      (0.13–∞)
Fixation 
  Cemented (944)  5  1    10  1    2  1    3  1      6  1
  Uncemented  2  0.28  0.24  18   1.4  0.56  2  1.2    1.0  2  0.91  1.0  3  1.4  0.9
   (523)    (0.03–1.8)      (0.59–3.4)      (0.08–17)      (0.07–9.9)      (0.21–7.6)
In the analyses, some cases were excluded due to missing values (i.e. patients with diagnoses other than the major ones). 
a Number of revisions due to each cause. 
b Adjusted for age and sex. Revision due to pain was significantly less frequent in patients who were 70 years or older compared to those who 
were younger (RR = 0.25, p = 0.005).
c OA: osteoarthritis; IA: inflammatory arthritis including RA, psoriatic arthritis, and ankylosing spondylitis.
d Pain was registered only when it was given as the only cause of revision.
Table 6b. Risk of revision due to specific causes, after reversed TSR, according to shoulder disease and fixation. The results were obtained 
using an exact regression model 
  Aseptic loosening   Pain d   Deep infection   Instability   Luxation of prosthesis
  n a   RR b   p  n a  RR b   p  n a  RR b  p   n a   RR b  p   n a    RR b  p
    (95% CI)        (95% CI)      (95% CI)      (95% CI)      (95% CI)  
Shoulder disease  
  IA d (120)  9  1    1  1    2  1    1  1    2  1
  OA d (47)  3  1.6  0.8  1  2.2  1   0  2.0  1  1  1.3   1.0  2   2.1   0.9
      (023–8.4)      (0.03–164)      (0.0–26)      (0.02–106)      (0.13–38)
  Sequelae of  1  0.62   1  0  4.3  1  1  1.8   1  0  6.5   1.0   0   1.4    1      
    fracture (296)    (0.01–5.7)      (0.0–166)      (0.03–35)      (0.0–252)      (0.00–18)
Fixation 
  Cemented (61)  1  1    1  1    1  1    0  1    2  1
  Uncemented  13  1.5  1  1   0.08  0.4  4  0.15    1  2  0.68  1.0  2  0.31  0.5
   (264)    (0.19–68)      (0.0007–9.4)     (0.0004–∞)      (0.05–∞)      (0.02–4.6)
In the analyses, some cases were excluded due to missing values (i.e. patients with diagnoses other than the 3 major ones). 
a Number of revisions due to each cause. 
b Adjusted for age and sex. Revision due to deep infection was significantly less frequent in women than in men (RR = 0.06, p = 0.01).
c Loosening of humeral or glenoid component, or both. 
d OA: osteoarthritis; IA: inflammatory arthritis including RA, psoriatic arthritis, and ankylosing spondylitis.
e Pain was registered only when it was given as the only cause of revision.90  Acta Orthopaedica 2009; 80 (1): 83–91
no information concerning the number of patients suffering 
from pain without being revised. Consequently, comparison of 
failure rates for different joints is difficult. Use of revision as 
outcome factor does, however, allow comparison of results for 
subgroups of patients with arthroplasties of the same joint. 
The disease leading to the hemiarthroplasty influenced the 
outcome. Patients who were operated due to sequelae after a 
previous fracture had worse prognosis than patients with IA 
and acute fractures. Haines et al. (2006) also found the high-
est revision rate following shoulder arthroplasty in patients 
with posttraumatic arthritis. Sperling et al. (2007) reported a 
5-year survival rate of 90% in 108 patients with RA who had 
a hemiarthroplasty, and Trail and Nuttall (2002) reported an 
8-year survival of 92% in a study of 105 patients with rheu-
matoid arthritis who were treated with HP or TSR. Robinson 
et al. (2003) reported 94% prosthesis survival at 10 years in 
163 patients treated with hemiarthroplasty due to proximal 
humeral fractures. 
We found no statistically significant difference in failure 
rates  for  the  different  brands  of  hemiprostheses.  Different 
brands would be best compared in randomized studies, but as 
far as we know, no such studies have been published. Reg-
ister studies, however, have been proven useful in pointing 
out inferior brands of prosthesis or cement, due to the long 
observation time and large number of patients (Furnes et al. 
1997, Espehaug et al. 2002). Thus, we may conclude that no 
particular brand of prosthesis had markedly inferior or supe-
rior results. 
We found that the risk of revision was dependent on age. 
The failure rate was doubled in patients younger than 70 years, 
compared to those who were older. This has been shown pre-
viously for patients with hip and knee prostheses (Havelin et 
al. 1994, 2000), but not in shoulder arthroplasty. 
Revision after total shoulder arthroplasty
Previous studies on TSR have reported 10-year survival rates of 
between 93% and 97% (Torchia et al. 1997, Sperling et al. 2004, 
2007, Deshmukh et al. 2005), which is much better than the 
78% for reversed TSR in our study. Only Neer prostheses were 
used in these studies, as opposed to the reversed TSRs in our 
study. The survival results were, however, no better for the 69 
Neer-type TSRs in our study. In a study of reverse total shoulder 
replacements, the 5-year survival was 91%, with replacement of 
the prosthesis as endpoint (Guery et al. 2006). These results are 
similar to ours, in which the 5-year survival for reversed total 
prostheses was 90%. The failure rate was higher for men than 
for women. A similar finding has been reported previously for 
total hip replacement (Havelin et al. 1994). 
The  indication  for  choosing  one  or  other  prosthesis  is 
unknown in register studies, but as hemiarthroplasty was “the 
treatment of choice”, we cannot exclude the possibility that 
it was used in most “uncomplicated” cases—possibly con-
tributing to the superior results with HP compared to TSR. 
Furthermore, the volume of TSR surgery at each hospital was 
lower than for HP. Surgeons’ experience in performing TSR 
is most probably less, and this may contribute to the inferior 
results for TSR. The use of reversed TSR is recommended 
for older patients, preferably 70 years or older (Matsen et al. 
2007). In our study, the mean age at surgery was the same for 
reversed TSRs as for HPs (69 years). The use of reversed TSR 
in younger patients may, to some degree, have influenced the 
results adversely. 
Cause of revision
Glenoid loosening was the most common cause of revision in 
patients with reversed TSR (Table 5). This corresponds well 
with that reported in other studies of reversed TSR (Nwakama 
et al. 2000, Rittmeister and Kerschbaumer 2001, Sirveaux et 
al. 2004, Bohsali et al. 2006). In our study, the major cause of 
revision after insertion of hemiprostheses was pain. This was 
seen in 15 of 439 cases with RA, while none of the 422 cases 
with acute fracture had a revision due to pain. The reason 
for this is most likely that patients with IA often have some 
involvement of the glenoid, which may cause pain after inser-
tion of a hemiprosthesis. The opposite is seen with acute prox-
imal humeral fractures in which only the humerus is involved 
and the glenoid is unaffected. 
Strength and weaknesses of the study
One weakness of our study is that the use of different types 
and  brands  of  prostheses  might  not  have  been  randomly 
assigned. We have, however, adjusted for known possible 
confounding factors such as age, sex, year of surgery, and 
diagnosis, using regression analysis. Comparison of differ-
ent subgroups should be made with caution, knowing that 
unknown factors may have influenced the results. The regis-
ter has no data on function after shoulder arthroplasty. Thus, 
a follow-up study of postoperative function and pain in our 
patients is planned. 
The use of registry data provides some advantages, in that 
we have almost complete data over a particular time period for 
a whole country, which represents a large study population. In 
addition, the results were obtained from all types of institu-
tions—small and large—for all surgeons and for all diagnoses. 
Most other studies present the results of a single institution 
and often of a few specialized surgeons using one or a small 
number of prosthesis brands. The results of our study may be 
more easily generalized to the average hospital and surgeon. 
In register studies, revision is used as the outcome factor after 
joint replacement surgery. However, patients may suffer from 
pain but may still not have their implant replaced due to known 
difficulties during replacement surgery. Such situations may 
be different for different joints (i.e. hips versus shoulders), and 
also in patients with different diseases. Even so, a close rela-
tionship between rate of revision and the rate of radiographic 
failure has been shown previously (Fender et al. 1999), sup-
porting the use of registry data (with revision as the outcome 
factor) for the surveillance of joint replacement surgery. Acta Orthopaedica 2009; 80 (1): 83–91  91
In  summary,  the  failure  rate  after  insertion  of  primary 
hemiprostheses was low. Patients with sequelae after fracture 
had a significantly higher risk of revision after hemiarthroplasty 
than patients with acute fracture or inflammatory arthritis. This 
might advocate more frequent use of HP for acute fractures, 
possibly reducing the need for arthroplasty due to sequelae 
after fractures. Reversed TSR was used in patients younger 
than 70 years of age, but this could not fully explain the rela-
tively disappointing results with this type of prosthesis.
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